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Abstract
We are investigating the biological and biomedical imaging roles and impacts of fluorescent 
metallocorrole-TiO2 nanoconjugates as potential near-infrared optical contrast agents in vitro in 
cancer and normal cell lines. The TiO2 nanoconjugate labeled with the small molecule 2,17-
bis(chlorosulfonyl)-5,10,15-tris(pentafluorophenyl)corrolato aluminum(III) (1-Al-TiO2) was 
prepared. The nanoparticle 1-Al-TiO2 was characterized by transmission electron microscopy 
(TEM) and integrating-sphere electronic absorption spectroscopy. TEM images of three different 
samples of TiO2 nanoparticles (bare, H2O2 etched, and 1-Al functionalized) showed similarity in 
shapes and sizes with an average diameter of 29 nm for 1-Al-TiO2. Loading of 1-Al on the TiO2 
surfaces was determined to be ca. 20–40 mg 1-Al/g TiO2. Confocal fluorescence microscopy 
(CFM) studies of luciferase-transfected primary human glioblastoma U87-Luc cells treated with 
the nanoconjugate 1-Al-TiO2 as the contrast agent in various concentrations were performed. The 
CFM images revealed that 1-Al-TiO2 was found inside the cancer cells even at low doses (0.02–2 
µg/mL) and localized in the cytosol. Bioluminescence studies of the U87-Luc cells exposed to 
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various amounts of 1-Al-TiO2 showed minimal cytotoxic effects even at higher doses (2–2000 
µg/mL) after 24 h. A similar observation was made using primary mouse hepatocytes (PMH) 
treated with 1-Al-TiO2 at low doses (0.0003–3 µg/mL). Longer incubation times (after 48 and 72 h 
for U87-Luc) and higher doses (> 20 µg/mL 1-Al-TiO2 for U87-Luc and > 3 µg/mL 1-Al-TiO2 for 
PMH) showed decreased cell viability.
Graphical Abstract
Synopsis for the graphic abstract
Fluorescence (shown in red) from the corrole nanoconjugate 1-Al-TiO2 internalized in the 
glioblastoma U87-Luc cell.
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1. Introduction
Small molecules, biomolecules, and biocompatible materials for molecular imaging have 
played an important role in recent advances in biomedical and drug development 
research[1–3]. Application of contrast agents is required by many imaging modalities and 
allows for better understanding of biochemical pathways, physiological processes, and 
disease pathologies[4–8]. Many small molecules and biomolecules that function as 
molecular imaging contrast agents have been utilized in both preclinical and clinical 
settings[9]. Recent efforts have focused on nanomaterials, a stark contrast to traditional 
small molecules and oligomers[10,11]. Aside from the sizes of these materials, including 
volumes and surface areas, which essentially provide a canvas for numerous small molecule 
labeling, they exhibit properties not generally found in either bulk materials or discreet 
molecules[12–14]. Examples of widely used and studied nanomaterials for biomedical 
imaging include quantum dots for optical imaging and superparamagnetic iron oxides for 
magnetic resonance imaging[10,11].
In our work, we have employed semiconductor nanoparticulate titanium(IV) oxide (TiO2) 
covalently decorated with fluorescent corroles as a new class of optical imaging contrast 
agents for the study of cellular uptake and cytotoxic effects in cancer and normal cells. TiO2, 
found in several different crystalline structures, such as rutile, anatase, and brookite, has 
been used in a number of contexts, including photocatalysis, dye-sensitized solar cells, and 
photochromic devices[15–19]. TiO2 nanoparticles exhibit a wealth of intrinsic properties 
dependent upon several factors, including surface area, crystalline phase, and single 
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crystallinity. We have exploited the facile nature with which the surface can be decorated 
with corroles, which were selected as optical dyes. Many studies have shown that 5,10,15-
trispentafluorophenyl corrole and its derivatives exhibit bright and robust fluorescence 
signals in the near-IR region (λem ≥ 600 nm) and are therefore considered suitable 
candidates for optical imaging[20–23]. In addition, the chemical versatility of corroles, 
allowing for various metallation[24–26] and substitution[27,28] reactions, as well as their 
biological stability[29–31] make them attractive contrast agents.
Previously we reported the syntheses, spectroscopic characterizations, and spectral confocal 
fluorescence imaging results for a family of corrole-TiO2 nanoconjugates, namely 1-TiO2, 1-
Al-TiO2, and 1-Ga-TiO2[32]. The TiO2 nanoparticle surfaces were covalently labeled with 
chlorosulfonated corroles through a sulfonic ester linkage (Scheme 1).
Because 1-Al-TiO2 exhibits the brightest fluorescence, consistent with the emission 
properties of related molecular Al corroles[26,32,33], we chose this nanoconjugate as a 
model to study cellular uptake and cytotoxic effects.
2. Experimental
2.1. Reagents and materials
Preparation of Al(III)tpfc(SO2Cl)2 (1-Al) and the nanoconjugate 1-Al-TiO2 was reported 
previously[32]. D-Luciferin potassium salt (Promega), Hoechst 34580 (Invitrogen™), 
Hoechst 33258 (Invitrogen™), Sytox Green (Invitrogen™), and FM® 1–43FX 
(Invitrogen™) were used as received according to the provider’s instruction.
2.2. Physical Methods
Characterization of 1-Al was performed by 1H NMR, 19F NMR, electronic absorption, and 
fluorescence spectroscopies, and was reported previously[32]. Surface characterization of 1-
Al-TiO2 is outlined as follows.
2.2.1. Transmission Electron Microscopy—The morphologies of the TiO2 
nanoparticles before and after surface functionalization were imaged using a FEI Tecnai 
F30ST transmission electron microscope (TEM) operated at acceleration voltage of 300 kV. 
Images were recorded using a Gatan CCD camera. For TEM analysis, a small quantity of 
TiO2 particles was dispersed in isopropyl alcohol (IPA) by sonication. The dispersions were 
drop-cast onto C-flat™ holey carbon films on a 200 mesh Cu TEM grid (Electron 
Microscopy Sciences).
2.2.2. Absorption Spectroscopy—Calculation of the corrole 1-Al’s loading on the 
surface of TiO2 was based on the absorbance values obtained from the integrating sphere 
electronic absorption measurements described as follows.
Thin film transflectance measurements were used to determine 1-Al loading on the TiO2 
nanoparticles. Both H2O2-etched and 1-Al-functionalized nanoparticles were dispersed in a 
polydimethylsiloxane (PDMS) polymer matrix. PDMS was chosen as it provides a 
transparent matrix for measuring the optical properties of porous solids[34]. The weights of 
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the TiO2 nanoparticles, the PDMS base (Sylgard®184 silicone elastomer base from Dow 
Corning), and the curing agent (Sylgard®184 silicone elastomer curing agent from Dow 
Corning) are provided in Table A.1 in Appendix A. The nanoparticles were first dispersed in 
a minimal amount of IPA by sonication. The dispersion of TiO2 nanoparticles in IPA was 
then mixed with the PDMS base and curing agent using a vortex mixer. The mixtures were 
cast into films onto quartz substrates and allowed to cure in air for 12 h followed by curing 
in a drying oven at 60° for 2 h.
Transflectance spectra of the H2O2-etched and 1-Al-functionalized TiO2 nanoparticle films 
were measured using a Cary 5000 UV-vis-NIR spectrometer from Agilent Technologies 
equipped with an integrating sphere (External DRA 1800), a PMT detector, a quartz-iodine 
lamp for the visible region (350–800 nm), and a deuterium lamp for the ultraviolet region 
(300–350 nm). Because the TiO2 nanoparticles diffusely scattered the incident illumination, 
the PDMS films were placed in the center of the integrating sphere to collect both the 
transmitted, T, and the reflected, R, (including the spectrally reflected and diffusely 
scattered) light with the PMT detector. The transflectance measurements allowed for the 
absorbance, A, of the films to be determined by A = −log(T+R). The concentration, C, of 1-
Al within the PDMS films was then calculated using the Beer-Lambert law, A = εCl, where 
ε is the extinction coefficient of the dye and l is the film thickness (determined by 
profilometry, see below)[35– 37]. The absorbance values at 426 and 595 nm (corresponding 
to the Soret and Q bands of the dye, respectively) for the PDMS film containing the 1-Al-
functionalized TiO2 nanoparticles, the estimated extinction coefficients of 1-Al at these 
wavelengths, and the film thicknesses are provided in Table A.2 of Appendix A. The 
absorbance values for the PDMS film containing the non-functionalized, H2O2-etched TiO2 
nanoparticles at these wavelengths are also provided, which were subtracted from the 
absorbance values of the 1-Al-functionalized TiO2 nanoparticles. The 1-Al-loading was 
determined to be 24 mg of 1-Al per gram of TiO2 based on the absorbance value of the Soret 
band and 38 mg of dye per gram of TiO2 based on the absorbance value of the Q band.
Thickness profiles of the PDMS films were measured using a Bruker DektakXT stylus 
surface profilometer. The diameter of the diamond-tipped stylus was 2 µm and a weight of 1 
mg was applied to the film. The stylus was scanned at a rate of 250 µm/s. The thickness 
profiles were used measure the average path length through the PDMS films during the 
transflectance measurements.
2.2.3. Hydrodynamic size and surface charge measurements—The mean particle 
size was determined by dynamic light scattering (DLS, Malvern ZEN 3600 Zetasizer Nano) 
measurements. Samples of 1-Al-TiO2 suspended in PBS pH 7.2 were pipetted into a low 
volume quartz cuvette with appropriate concentrations. At least nine measurements were 
performed for each sample. Each measurement comprised 20 runs with an average of 34,000 
particle counts per second. The data represent the particle size distribution parameter, which 
reports the most frequent particle size in the sample accounting for the intensity fluctuations 
of larger particles. The particle intensity was computed using Zetasizer Software version 
7.01 applying the Stokes-Einstein equation to correlate the change in the scattering intensity 
and particle movements. Plots showing the average size of the nanoparticle aggregates are 
shown in Figure A.1. The surface charge of 1-Al-TiO2 in PBS pH 7.2 was examined through 
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ζ potential measurements (Malvern ZEN 3600 Zetasizer Nano). The average ζ potential 
(Table A.3) was calculated from 20 measurements with 10–100 runs for each depending on 
the variation of the particles.
2.3. Cell Culture and Cell Viability Assay
Pathogen-free U87-LUC cell line (TSRI Small Animal Imaging and Research Laboratory)
[38] was grown in a 75-mL flask in Dulbecco’s Minumal Essential Medium (DMEM) in 5% 
CO2 at 37 °C. The cell culture medium was supplemented with 10% fetal bovine serum 
(FBS) and 1% antibiotic primocin. The cell culture medium was replenished every 2 days 
and the cells were passaged once they reached 80% confluence. Primary mouse hepatocytes 
(PMH) were isolated and cultured as previously described[39].
For U87-Luc cell culture experiments, cells plated in an 8-chamber slide (Nunc™ Lab-
Tek™, Thermo Scientific) were treated with 1-Al-TiO2 suspended in PBS over a range of 
0.002 µg/mL to 2000 µg/mL. A primary stock solution (6.3 mg 1-Al-TiO2 in 1 mL PBS) was 
prepared. The primary stock solution was further diluted to prepare secondary and tertiary 
stock solutions. Various amounts of stock solutions were added to the 8-chamber glass slide 
plated with cells to give the aforementioned range of concentrations. The final volume of 
each chamber was 300 µL. After treatment, the treated cells and controls were incubated in 
the dark in 5% CO2 at 37 °C for a period of 24, 48, and 72 h. The cells were imaged using a 
cooled IVIS® animal imaging system (Xenogen, Alameda, CA USA) linked to a PC running 
with Living Image™ software (Xenogen) along with IGOR (Wavemetrics, Seattle, WA, 
USA) under Microsoft® Windows® 2000. This system yielded high signal-to-noise images 
of luciferase signals emerging from the cells. Before imaging, 20 µL of 5 mg/mL luciferin in 
normal saline were added to each well. An integration time of 1 min with binning of 5 min 
was used for luminescent image acquisition. The signal intensity was quantified as the flux 
of all detected photon counts within each well using the LivingImage™ software package. 
All experiments were performed in triplicate.
For PMH cell culture experiments, the cells were plated in a 6-chamber slide (Falcon®, 
Primaria™). After 3 h, media was exchanged (DMEM-F12) and the cells were treated with 
1-Al-TiO2 suspended in PBS over a range of 0.0003 to 300 µg/mL. A primary stock solution 
(6.3 mg 1-Al-TiO2 in 1 mL PBS) was prepared. The primary stock solution was further 
diluted to prepare secondary and tertiary stock solutions. Various amounts of stock solutions 
were added to the 6-chamber glass slide plated with cells to give the aforementioned range 
of concentrations. The final volume of each chamber was 2000 µL. After 24 or 48 h of 
treatment, cells were double stained with Hoechst 33258 (8 mg/mL) and Sytox Green (1 
mM). Quantitation of total and necrotic cells (Sytox Green positive) was performed by 
counting cells in at least five different fields using ImageJ, as previously described[39]. All 
experiments were done in triplicate.
2.4. In Vitro Confocal Fluorescence Microscopy
The U87-Luc cells were seeded at 20,000 cells per well on an 8-chamber slide (Nunc™ Lab-
Tek™, Thermo Scientific) and allowed to grow overnight. Cells were washed with PBS and 
were incubated in serum free media mixed 1:1 with 1-Al-TiO2 for 24, 48, and 72 h at 37 °C 
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over a concentration range similar to that of the U87-Luc cell viability assay (0.002 µg/mL 
to 2000 µg/mL). Cells were then washed 3× with PBS and stained with Hoechst 33258 and 
FM® 1–43FX stains. The stained cells were kept chilled on ice without fixation until just 
prior to imaging. Z-stacked images were acquired with an LSM 710 confocal system 
mounted on an AxioObserver Z.1 inverted microscope equipped with a 40×/1.2 C-
APOCHROMAT water-immersion lens (Carl Zeiss Microimaging, Thronwood, NY). Two 
visible laser lines of 405 and 488 nm were used for fluorescence excitation. The Z-stacks 
were acquired with 0.5 µm slice intervals. The software ZEN 2010 was used for hardware 
control. To reduce blurring and noise in the raw images, they were processed with the 3D 
blind deconvolution algorithm of AutoQuant AutoDeblur software (Media Cybernetics, 
Silver Spring, MD) using the default settings for the laser scanning confocal modality. ZEN 
and Fiji ImageJ software[40] was employed to further process the deconvolved images.
3. Results and Discussion
3.1 Physical Characterization of 1-Al-TiO2: TEM, DLS, and Surface Characterization
TEM images of TiO2 (Figure 1) were taken before and after H2O2-etching and surface 
functionalization. The images established that the average particle size post-corrole 
functionalization is 29 nm with a standard deviation of 7 nm. These results were obtained 
through averaging over 44 particles. Absorption measurements of the particles embedded in 
a transparent polymer matrix, facilitated with the use of an integrating sphere to distinguish 
between absorption and diffuse scattering by the nanoparticles, indicated nearly identical 
absorption features in the molecular and conjugated species. These experiments afforded an 
approximate loading of 1-Al on the surfaces of ca. 20–40 mg/g TiO2 (Figure 2).
The hydrodynamic nature of 1-Al-TiO2 in PBS measured by the DLS method revealed great 
heterogeneity in size of the aggregates. While the average size of 1-Al-TiO2 in PBS was 
measured to be 200 nm in diameter, smaller and larger aggregates were observed (Appendix 
A). In addition, zeta (ζ) potential measurements of 1-Al-TiO2 in PBS exhibited moderate 
stability and revealed a negatively charged surface with a ζ potential of −27.4 (±1.25) mV at 
the concentration of 50 µg/mL.
3.2 Confocal Fluorescence Microscopy and Uptake of 1-Al-TiO2 by U87-Luc Cells
Treatment of the luciferase-transfected glioblastoma cell U87-Luc with a wide range of 1-
Al-TiO2 concentrations revealed internalization of these nanoconjugates over a period of 24, 
48, and 72 h as shown by CFM (Figure 3). We also show the Z-stacked three-dimensional 
CFM images (Figure 4) of U87-Luc cells treated with 0.02 µg/mL of 1-Al-TiO2 for 48 and 
72 h from three different perspectives.
The CFM images were taken after the cells were stained with nuclear and cell membrane 
dyes, and washed with media solution several times to remove unbound dyes and 1-Al-TiO2 
nanoconjugates. The nucleus labeled with a Hoechst stain is colored blue (λex = 405; λem = 
460 nm), the membrane labeled with the dye FM® 1–43FX is colored green (λex = 488; λem 
= 580 nm), and the nanoconjugate 1-Al-TiO2 is colored red (λex = 405; λem = 634 nm).
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While mechanisms of 1-Al-TiO2 uptake and localization into cells will be studied further, 
we propose that the 1-Al-TiO2 nanoconstruct is internalized through endocytosis, consistent 
with previous work[41–46]. We note that, based on confocal fluorescence imaging, the 
nanomaterial 1-Al-modified TiO2 appears to be suspended in the cytosol. This finding is 
consistent with the distribution pattern of TiO2 nanoconjugates in HeLa cells in a previous 
study of 1D TiO2 nanorods and nanoparticles labeled with fluorescein thiocyanate[43]. 
However, modified TiO2 labeled with alizarin red S has been shown to have perinuclear 
localization in HeLa cells, in contrast to our observations with 1-Al-TiO2[41,42]. Recent 
studies involving uptake of other modified TiO2 nanoparticles in various cell lines, such as 
mouse fibroblasts and osteoblasts, suggested cellular internalization and distribution of TiO2 
nanoparticles at the endosome/lysosome and in the cytoplasm, in accord with our 
findings[44,45]. We note that internalization of 1-Al-TiO2 into glioblastoma cells can be 
observed at very low concentrations (0.02–2 µg/mL).
3.3 Cytotoxicity in U87-Luc Cells
It is well documented that TiO2 nanoparticles exhibit various degrees of cytotoxic activity 
upon photoactivation by UV-vis light due to formation of reactive oxygen species[43,44,46]. 
A study of water-soluble single-crystalline TiO2 nanoparticles in melanoma A-375 cells 
revealed that in the absence of UV light the TiO2 nanoparticles were essentially non-toxic 
and thus biocompatible[46]. However, upon irradiating these cells with UV light less than 
20% of the melanoma cells survived at a TiO2 concentration of 400 µg/mL. Therefore, in an 
attempt to understand the cytotoxic effects of the 1-Al-TiO2 conjugate independently of its 
phototoxic properties, we treated the glioblastoma cell U87-Luc in the absence of UV-vis 
irradiation with the same range of 1-Al-TiO2 concentrations as in the cell internalization 
studies (0.002–2000 µg/mL). The cells were incubated over a period of 24, 48, and 72 h 
prior to bioluminescence cell viability assays[38,47]. Based on the bioluminescence signal 
of the firefly luciferin from living U87-Luc cells, which is related to the level of cellular 
ATP, the cytotoxic assay showed that the nanoconjugate 1-Al-TiO2 had essentially no 
cytotoxic effect on the glioblastoma cells after 24 h of treatment (Figure 5) and, therefore, 
could be considered biocompatible. The cytotoxic effect became more apparent as the cells 
were exposed to the corrole-TiO2 nanoparticles for extended periods of time at higher 
concentrations (> 200 µg/mL). For example, only ca. 65% and ca. 30% of the 
bioluminescence signal from the live cells was observed after 48-h and 72-h treatments at 
2000 µg/mL, respectively. Our viability study of the U87-Luc cells treated with 1-Al-TiO2 
was also consistent with a study performed on mouse fibroblast cells, using the MTT assay, 
showing that the cytotoxic effects of TiO2 at various concentrations (3–600 µg/mL) were 
negligible after 24 h of treatment, whereas the 48-h treatment of these cells with the 
nanoparticle showed a decrease in cell viability at higher concentrations[44]. Another study 
on the cytotoxicity effect of unmodified 1D and 3D TiO2 nanostructures on HeLa cells also 
showed that these nanoparticles were relatively nontoxic at concentrations up to 125 µg/mL 
in the absence of light[43].
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3.4 Cytotoxicity in Primary Mouse Hepatocytes
Additionally, to determine the cytotoxic effect of the nanoconjugate 1-Al-TiO2 on non-
cancerous cells, we treated primary mouse hepatocytes (PMH) with 1-Al-TiO2 at various 
concentrations (0.0003–300 µg/mL) for 24 and 48 h (Figure 6) in the absence of UV-vis 
irradiation. Similar to the results observed for cancerous U87-Luc cells, 1-Al-TiO2 was 
essentially nontoxic in non-cancerous PMH at up to 3 µg/mL after both 24 and 48 h of 
treatment. Only at higher concentrations did the proportion of the live PMH drop below 
80%. We note that the PMH behaved similarly after 24-h and 48-h treatments with various 
doses of 1-Al-TiO2, suggesting that low 1-Al-TiO2 concentrations had minimal cytotoxic 
effects on the viability of these non-cancerous cells. The PMH were more susceptible to the 
cytotoxic effects of 1-Al-TiO2 than the U87-Luc cells; it is reasonable that non-cancerous 
cells, especially primary cells, would be less tolerant towards exogenous non-native 
agents[48,49]. Nonetheless, the intense fluorescence exhibited by 1-Al[26,33] would allow 
for the potential use of the nanoconjugate 1-Al-TiO2 as an optical imaging agent observable 
by confocal fluorescence microscopy even at low concentrations (0.02–2 µg/mL) below the 
cytotoxic thresholds for both cancerous and non-cancerous cells.
4. Conclusions
In summary, we report detailed characterization of 1-Al-TiO2, a nanoconjugate that 
potentially could be used as a metal oxide nanoprobe for optical imaging, owing to intense 
fluorescence as well as its biocompatibility. The biological studies suggest that 1-Al-TiO2 is 
essentially nontoxic at concentrations up to 3 and 2000 µg/mL for normal mouse liver cells 
and glioblastoma U87-Luc cells, respectively, within the first 24 h of treatment. The PMH 
viability, however, dropped at higher concentrations (> 3 µg/mL) after 24-h and 48-h 
treatments and the U87-Luc cell viability also declined at higher concentrations (> 20 
µg/mL) after 48-h and 72-h treatments. We also would like to note, for example, that 
comparable to our PMH cytotoxic assay over the concentration range for 1-Al-TiO2 of 
0.0003–300 µg/mL, superparamagnetic iron oxide nanoparticle used in MRI was studied for 
their cytotoxicity in fetal stem cell lines over a low concentration range (5–35 µg/mL)[50]. 
Another example includes PDMAEMA-modified ZnO QDs functioning as contrast agents in 
monkey kidney cells over a concentration range of 50–800 µg/mL[51]. More importantly, 
our CFM studies demonstrated that the nanoconjugate 1-Al-TiO2 was internalized in U87-
Luc cells even at a relatively low concentration (0.02 µg/mL). Although further detailed 
localization and internalization mechanism studies should be performed, our current work 
has revealed that there is random suspension of 1-Al-TiO2 in the cytosol even after 72-h 
treatment. Notably, the observation of near-IR fluorescence of 1-Al-TiO2 over a non-toxic 
concentration range (0.002–2000 µg/mL) in U87-Luc after 24-h treatment suggests that 
corrole-TiO2 nanoconjugates could be very promising candidates for use as biological 
imaging agents.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• We examined a potential use of the corrole nanoconjugate 1-Al-TiO2 as 
an optical imaging contrast.
• 1-Al-TiO2 showed biocompatibility in both primary mouse hepatocyte 
and the glioblastoma U87-Luc.
• 1-Al-TiO2 was internalized by U87-Luc cells even after a long-term 
treatment (72 h).
• 1-Al-TiO2 showed intense near-IR fluorescence inside U87-Luc cells 
even at low doses of treatment (0.02–2 µg/mL)
• We reported detailed characterization of 1-Al-TiO2, including its 
hydrodynamic size, surface charge, and corrole loading.
Blumenfeld et al. Page 11
J Inorg Biochem. Author manuscript; available in PMC 2016 August 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
TEM images of TiO2 nanoparticles before and after dye-functionalization. Images of the 
initial TiO2 nanoparticles (a and d). Images of the nanoparticles after H2O2-etching (b and 
e). Images of the nanoparticles after 1-Al functionalization (c and f). The top scale bar refers 
to images a, b, and c and the bottom scale bar refers to images d, e, and f.
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Figure 2. 
Absorbance spectra of H2O2-etched TiO2 nanoparticles embedded in a PDMS polymer 
matrix before (blue, long dashed line) and after 1-Al functionalization (red, solid line), as 
well as the absorption spectrum of PDMS on quartz (black, short dashed line). The 
absorption spectra were measured in transflectance mode where both transmitted and 
reflected lights were collected employing an integrating sphere.
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Figure 3. 
CFM images of U87-Luc cells incubated with 0.02 µg/mL 1-Al-TiO2 (red) for 24 h (a), 48 h 
(b), and 72 h (c) and stained with dyes to mark the membrane (green) and nucleus (blue).
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Figure 4. 
Z-stacked CFM images of individual U87-Luc cells taken at 0.5-µm z-slice intervals from 
top to bottom after (a) 48 h and (b) 72 h of treatment with 0.02 µg/mL 1-Al-TiO2.
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Figure 5. 
Cell viability plot of U87-Luc cells treated by 1-Al-TiO2 at various concentrations (0.002–
2000 µg/mL) using a bioluminescence assay.
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Figure 6. 
Cell viability plot of PMH treated with 1-Al-TiO2 at various concentrations (0.0003–300 
µg/mL) using a Syntox Green live-dead assay.
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Scheme 1. 
TiO2 surface labeling with 1-Al forming sulfonic ester linkages between the corrole and the 
surface.
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